E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
Darren K. McGuire,L. Kristin Newby,Manjushri Bhapkar,David J. Moliterno,Judith S. Hochman,Werner Klein,W. Douglas Weaver,Matthias Pfisterer,Ramón Corbalán,Mikael Dellborg,Christopher B. Granger,Frans V. Van De Werf,Eric J. Topol,Robert M. Califf +13 more
TL;DR: Although the findings regarding the influence of glycemic-control strategies should be interpreted with caution because of the exploratory nature of the analyses and the relatively small sample size of the insulin-sensitizing group, the improved risk-adjusted outcomes associated with insulin-aided therapy underscore the need to further evaluate treatment strategies for patients with diabetes and CAD.
Journal ArticleDOI
Four SNPS on chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian population (GeneQuest).
Kalil G. Abdullah,Lin Li,Gong Qing Shen,Y. Hu,Y. Yang,K. G. MacKinlay,Eric J. Topol,Qing Kenneth Wang +7 more
TL;DR: Sib‐TDT analysis showed that three of the four SNPs could confer significant susceptibility to premature CAD and MI, indicating that the fourSNPs on chromosome 9p21 are also associated with premature, familial CAD.
Journal ArticleDOI
Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
TL;DR: These data show that inhibition of specific pathways of platelet and thrombin activity improves the extent and duration of rTPA-induced thrombolysis in the electrolytic canine model and suggest that low doses of platelets IIb/IIIa and direct throm bin antagonists in combination may be used successfully during thrombosis.
Journal ArticleDOI
Dynamic QRS complex and ST segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy
TL;DR: It is suggested that QRS complex and ST segment monitoring with continuous on-line vectorcardiography has substantial potential for monitoring patients with acute myocardial infarction treated with reperfusion therapy.
Journal ArticleDOI
Diabetic Retinopathy Should Not Be a Contraindication to Thrombolytic Therapy for Acute Myocardial Infarction: Review of Ocular Hemorrhage Incidence and Location in the GUSTO-I Trial
Kenneth W. Mahaffey,Christopher B. Granger,Cynthia A. Toth,Harvey D. White,Amanda Stebbins,Gabriel I. Barbash,Alec Vahanian,Eric J. Topol,Robert M. Califf +8 more
TL;DR: It is concluded that diabetic retinopathy should not be considered a contraindication to thrombolysis in patients with an acute myocardial infarction.